# QRICH1

## Overview
QRICH1 is a gene that encodes the protein glutamine-rich 1, which plays a crucial role in cellular stress responses and proteostasis, particularly during endoplasmic reticulum (ER) stress. The protein is characterized by a high glutamine content and contains a caspase activation and recruitment domain (CARD) and a domain of unknown function (DUF3504), suggesting its involvement in apoptosis, inflammation, and immune responses (Kumble2021The). Glutamine-rich 1 functions as a transcriptional regulator within the nucleus, modulating the integrated stress response (ISR) through the PERK-eIF2α axis, which is essential for maintaining cellular homeostasis under stress conditions (You2021QRICH1). The gene's activity is linked to various developmental processes, and its mutations are associated with neurodevelopmental disorders and certain cancers, highlighting its significance in both normal physiology and disease states (Föhrenbach2020QRICH1; Zhao2024QRICH1).

## Structure
The QRICH1 gene encodes a protein known as Glutamine-rich protein 1, which consists of 776 amino acids and is characterized by a high glutamine content. This protein has 11 isoforms that differ only at the 5' end, all encoding the same protein sequence (Kumble2021The). The primary structure of QRICH1 includes two conserved domains: the CARD domain (caspase activation and recruitment domain) at the N-terminal end and the DUF3504 (domain of unknown function) at the C-terminal end, with a glutamine-rich region in between (Kumble2021The). The CARD domain is involved in protein-protein interactions and is commonly found in proteins associated with apoptosis, inflammation, and immune responses (Kumble2021The).

Attempts to model the 3D structure of QRICH1 have been challenging, but sequence-structure relationships have been analyzed using Phyre2, predicting secondary structures in the protein, including the CARD and DUF3504 domains (Kumble2021The). The DUF3504 domain shows significant homology with DNA-binding proteins, suggesting a potential role in genomic rearrangements, although its exact function remains uncharacterized (Kumble2021The). QRICH1 is suggested to play a role in the unfolded protein response of endoplasmic reticulum stress through transcriptional control of proteostasis (Kumble2021The).

## Function
QRICH1 (glutamine rich 1) is a gene that encodes a protein involved in maintaining proteostasis and managing cellular stress responses, particularly during endoplasmic reticulum (ER) stress. In healthy human cells, QRICH1 functions as a transcriptional regulator, modulating the integrated stress response (ISR) through the PERK-eIF2α axis. This regulation is crucial for balancing protein synthesis and secretion, which are vital for cell viability and adaptation to stress conditions (You2021QRICH1).

QRICH1 is active in the nucleus, where it influences gene expression by binding to promoter regions of genes related to protein production, such as those involved in ribosome biogenesis and mRNA processing. It co-occupies gene regions with ATF4, which are enriched for tRNA metabolism, essential for secreted protein synthesis during ER stress (You2021QRICH1). QRICH1's role in the PERK-eIF2α axis helps modulate the unfolded protein response (UPR), determining whether cells enter an adaptive or terminal UPR, thus maintaining cellular homeostasis (You2021QRICH1).

The gene's activity is also linked to developmental processes, with mutations in QRICH1 associated with developmental disorders. It plays a role in synaptic plasticity and memory formation, impacting dendritic spines and synaptic function (You2021QRICH1).

## Clinical Significance
Mutations and altered expression of the QRICH1 gene are associated with several neurodevelopmental disorders and cancers. QRICH1 mutations, including nonsense, frameshift, and missense variants, are linked to Ververi-Brady syndrome (VBS), a rare neurodevelopmental disorder. Patients with QRICH1 mutations often exhibit expressive speech delay, learning difficulties, intellectual disability, motor delay, microcephaly, short stature, and social behavior deficits (Föhrenbach2020QRICH1). QRICH1 variants are also associated with intellectual disability and autism spectrum disorder, with some cases showing developmental regression and seizures (Kumble2021The).

In pediatric T-cell acute lymphoblastic leukemia (T-ALL), low QRICH1 expression is an independent risk factor for poor prognosis. QRICH1 acts as a tumor suppressor by inhibiting cell proliferation and promoting apoptosis in T-ALL cells. It interacts with GRP78, a chaperone protein involved in the unfolded protein response, affecting its ATPase activity and leading to increased apoptosis (Zhao2024QRICH1).

QRICH1 is also implicated in inflammatory conditions such as inflammatory bowel disease, where its expression is upregulated in response to ER stress and inflammation (You2021QRICH1).

## Interactions
QRICH1 is known to interact with various proteins and nucleic acids, playing a significant role in cellular processes. One of its key interactions is with GRP78, a chaperone protein involved in the unfolded protein response (UPR). QRICH1 binds to specific residues in the nucleotide-binding domain of GRP78, inhibiting its ATPase activity. This interaction leads to the downregulation of GRP78, affecting UPR pathways and promoting apoptosis in T-cell acute lymphoblastic leukemia (T-ALL) cells (Zhao2024QRICH1).

QRICH1 also interacts with a wide array of proteins involved in various cellular functions. Immunoprecipitation experiments have identified 1,430 proteins interacting with QRICH1, which are associated with processes such as amino acid biosynthesis, RNA localization, and protein folding (Zhao2024QRICH1). These interactions suggest that QRICH1 is involved in complex regulatory networks within the cell.

In the context of ER stress, QRICH1 is implicated in the transcriptional control of proteostasis, working alongside ATF4 to regulate protein synthesis and secretion. This interaction is crucial for maintaining cell viability under stress conditions, highlighting QRICH1's role in modulating the cellular response to ER stress (You2021QRICH1).


## References


[1. (You2021QRICH1) Kwontae You, Lingfei Wang, Chih-Hung Chou, Kai Liu, Toru Nakata, Alok Jaiswal, Junmei Yao, Ariel Lefkovith, Abdifatah Omar, Jacqueline G. Perrigoue, Jennifer E. Towne, Aviv Regev, Daniel B. Graham, and Ramnik J. Xavier. Qrich1 dictates the outcome of er stress through transcriptional control of proteostasis. Science, January 2021. URL: http://dx.doi.org/10.1126/science.abb6896, doi:10.1126/science.abb6896. This article has 90 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.abb6896)

[2. (Kumble2021The) Smitha Kumble, Amanda M. Levy, Jaya Punetha, Hua Gao, Nicholas Ah Mew, Kwame Anyane‐Yeboa, Paul J. Benke, Sara M. Berger, Lise Bjerglund, Belinda Campos‐Xavier, Michael Ciliberto, Julie S. Cohen, Anne M. Comi, Cynthia Curry, Lena Damaj, Anne‐Sophie Denommé‐Pichon, Lisa Emrick, Laurence Faivre, Mary Beth Fasano, Alice Fiévet, Richard S. Finkel, Sixto García‐Miñaúr, Amanda Gerard, Paulino Gomez‐Puertas, Maria J. Guillen Sacoto, Trevor L. Hoffman, Lillian Howard, Alejandro D. Iglesias, Kosuke Izumi, Austin Larson, Anja Leiber, Reymundo Lozano, Iñigo Marcos‐Alcalde, Cassie S. Mintz, Sureni V. Mullegama, Rikke S. Møller, Sylvie Odent, Henry Oppermann, Elsebet Ostergaard, Marta Pacio‐Míguez, Maria Palomares‐Bralo, Sumit Parikh, Anna M. Paulson, Konrad Platzer, Jennifer E. Posey, Lorraine Potocki, Anya Revah‐Politi, Marlene Rio, Alyssa L. Ritter, Scott Robinson, Jill A. Rosenfeld, Fernando Santos‐Simarro, Sérgio B. Sousa, Mathys Wéber, Yili Xie, Wendy K. Chung, Natasha J. Brown, and Zeynep Tümer. The clinical and molecular spectrum of qrich1 associated neurodevelopmental disorder. Human Mutation, 43(2):266–282, December 2021. URL: http://dx.doi.org/10.1002/humu.24308, doi:10.1002/humu.24308. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.24308)

[3. (Föhrenbach2020QRICH1) Melanie Föhrenbach, Rami Abou Jamra, Arndt Borkhardt, Triantafyllia Brozou, Petra Muschke, Bernt Popp, Linda K. Rey, Jörg Schaper, Harald Surowy, Martin Zenker, Christiane Zweier, Dagmar Wieczorek, and Silke Redler. <scp>qrich1</scp> variants in <scp>ververi‐brady</scp> syndrome—delineation of the genotypic and phenotypic spectrum. Clinical Genetics, 99(1):199–207, November 2020. URL: http://dx.doi.org/10.1111/cge.13853, doi:10.1111/cge.13853. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.13853)

[4. (Zhao2024QRICH1) Ji’ou Zhao, Meiyun Kang, Huimin Li, Liucheng Rong, Yaping Wang, Yao Xue, Yuqian Yao, and Yongjun Fang. Qrich1 suppresses pediatric t-cell acute lymphoblastic leukemia by inhibiting grp78. Cell Death &amp; Disease, September 2024. URL: http://dx.doi.org/10.1038/s41419-024-07040-7, doi:10.1038/s41419-024-07040-7. This article has 0 citations.](https://doi.org/10.1038/s41419-024-07040-7)